These Are The Technical Guidelines For Giving Vaccines For The Elderly, Breastfeeding Mothers, Comorbids And COVID-19 Survivors

The vaccinator injects the first dose of the COVID-19 Sinovac vaccine into a health worker (Photo: Antara)

JAKARTA - The Ministry of Health, through the Directorate General of Disease Prevention and Control, issued a circular letter with Number HK.02.02 / 11/368/2021.

A circular contains the implementation of COVID-19 vaccination for the elderly, comorbid and COVID-19 survivors and targets for postponement.

In a copy of the circular reported by Antara, Friday, February 12, it was explained that the National Immunization Expert Advisory Committee has submitted a study that COVID-19 vaccination can be given to the age group of 60 years and over, comorbid, COVID-19 survivors and breastfeeding mothers with an anamnesa first. additional.

The implementation of vaccination follows the technical guidelines for the implementation of COVID-19 vaccination, including the Elderly Group by giving two doses of vaccination to the 60-year-old group with an interval of 28 days (0 and 28).

Furthermore, comorbid groups such as hypertension can be vaccinated unless the blood pressure is above 180/110 MmHg, and blood pressure measurements should be done before screening, diabetes can be vaccinated as long as there are no acute complications and cancer survivors can still be vaccinated after more than three months. , and nursing mothers can be given vaccinations.

The Ministry of Health asked regions to update the PCare application in order to facilitate renewal screening and re-registration of the delayed target.

Also all vaccination service posts must be equipped with an anaphylaxis kit and are under the responsibility of the health center or hospital.

All postponed targets will be provided with information to come back to the health care facility for vaccination.

Local governments are asked to immediately take necessary corrective actions in order to improve the smooth implementation of vaccinations and accelerate the increase in the coverage of COVID-19 vaccinations.